Hälsa & medicin
4.6
🇸🇪 🇺🇸
Popular obesity drugs show mixed results for sleep apnea patients
A new study questions whether GLP-1 medications like Ozempic and Wegovy effectively treat obstructive sleep apnea—a common but serious side effect of obesity. The finding matters to insurers, employers, and drug makers betting these medications will reduce costly sleep-related complications and hospitalizations.
Originaltitel: Hope or hype? Obesity management medications and real-world obstructive sleep apnea outcomes